Axonis

Axonis

Axonis

AXONIS Therapeutics, Inc. is advancing breakthrough drug discoveries from in vivo screens, to develop firstinclass CNS therapeutics for neurological disorders
Type
B2c
Founded
2017
Raised
$5M
Follow us
Alexa global traffic share
Latest funding
$5,000,000
Venture capital - 2021
Civilization Ventures Alexandria Venture Investments BoxOne Ventures +1
Team Size
1–10
Employees
$5,000,000 Venture capital
SiliconRepublic

Biotech co-founded by UCC graduates raises $5m funding